ekonominyheter

TranslateRSSMobil
CSL to Buy Novartis Influenza-Vaccine Unit for $275 Million

CSL to Buy Novartis Influenza-Vaccine Unit for $275 Million

Wall Street Journal 27/10 11:11

Blood products and vaccine maker CSL Ltd. agreed to buy Novartis AG?s influenza-vaccine business for $275 million, as the Australia-based company continues its global expansion.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status